Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation

Abstract

This study provides evidence that NOX2 is upregulated only in patients with paroxysmal/persistent AF and is responsible for overproduction of isoprostanes. This finding warrants further study to see if inhibition of NOX2 may reduce the risk of paroxysmal/persistent AF.

References

Page 1

	Year	Citations
Diagnosis and Classification of Diabetes Mellitus Diabetes Care	2010	14K
General Cardiovascular Risk Profile for Use in Primary Care Ralph B. D’Agostino, Ramachandran S. Vasan, Michael Pencina, Circulation	2008	7.2K
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach Gregory Y.H. Lip, Robby Nieuwlaat, Ron Pisters, CHEST Journal ThrombosisVenous ThrombosisCardiovascular EpidemiologyIschemic StrokeCardiovascular Disease	2009	6.6K
2007 Guidelines for the Management of Arterial Hypertension Giuseppe Mancia, Guy De Backer, Anna F. Dominiczak, Journal of Hypertension	2007	5.8K
2013 ESH/ESC Guidelines for the management of arterial hypertension Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, Journal of Hypertension	2013	5.6K
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) European Heart Journal	2006	2.4K
Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation Cynthia A. Carnes, Mina K. Chung, Tomohiro Nakayama, Circulation Research	2001	521
A Myocardial Nox2 Containing NAD(P)H Oxidase Contributes to Oxidative Stress in Human Atrial Fibrillation Young Mo Kim, Tomasz J. Guzik, Yin Hua Zhang, Circulation Research	2005	401
Atrial Fibrillation Increases Production of Superoxide by the Left Atrium and Left Atrial Appendage Samuel C. Dudley, Nyssa E. Hoch, Louise McCann, Circulation	2005	368
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation Volker Rudolph, René Andrié, Tanja K. Rudolph, Nature Medicine Molecular PhysiologyMedicinePhysiologyFibrinolysisAtrial Fibrillation	2010	348

Page 1